CUE – cue biopharma, inc. (US:NASDAQ)
Stock Stats
News
Cue Biopharma Announces Pricing of $10 Million Public Offering [Yahoo! Finance]
Cue Biopharma Announces Pricing of $10 Million Public Offering
Cue Biopharma Announces Proposed Public Offering
Cue Biopharma (NASDAQ:CUE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Cue Biopharma (NASDAQ:CUE) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Form 8-K Cue Biopharma, Inc. For: Dec 19
Form 424B5 Cue Biopharma, Inc.
Form 424B5 Cue Biopharma, Inc.
Form 4 Cue Biopharma, Inc. For: Sep 26 Filed by: Sandercock Colin
Form 4 Cue Biopharma, Inc. For: Sep 29 Filed by: Warren Lucinda
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.